Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses

Journal of Medicinal Chemistry
2010.0

Abstract

We have identified a virus, B/Perth/211/2001, with a spontaneous mutation, D197E in the neuraminidase (NA), which confers cross-resistance to all NA inhibitors. We analyzed enzyme properties of the D197 and E197 NAs and compared these to a D197N NA, known to arise after oseltamivir treatment. Zanamivir and peramivir bound slowly to the wild type NA, but binding of oseltamivir was more rapid. The D197E/N mutations resulted in faster binding of all three inhibitors. Analysis of the crystal structures of D197 and E197 NAs with and without inhibitors showed that the D197E mutation compromised the interaction of neighboring R150 with the N-acetyl group, common to the substrate sialic acid and all NA inhibitors. Although rotation of the E275 in the NA active site occurs upon binding peramivir in both the D197 and E197 NAs, this does not occur upon binding oseltamivir in the E197 NA. Lack of the E275 rotation would also account for the loss of slow binding and the partial resistance of influenza B wild type NAs to oseltamivir.

Knowledge Graph

Similar Paper

Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses
Journal of Medicinal Chemistry 2010.0
Structural Studies of the Resistance of Influenza Virus Neuramindase to Inhibitors
Journal of Medicinal Chemistry 2002.0
In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses
Antimicrobial Agents and Chemotherapy 2009.0
Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance
Antimicrobial Agents and Chemotherapy 2010.0
Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity
Bioorganic & Medicinal Chemistry 2018.0
Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors
Journal of Medicinal Chemistry 2016.0
Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase
Bioorganic & Medicinal Chemistry Letters 2014.0
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant
Journal of Medicinal Chemistry 2018.0
Dihydropyrancarboxamides Related to Zanamivir:  A New Series of Inhibitors of Influenza Virus Sialidases. 2. Crystallographic and Molecular Modeling Study of Complexes of 4-Amino-4H-pyran-6-carboxamides and Sialidase from Influenza Virus Types A and B
Journal of Medicinal Chemistry 1998.0